Superti-Furga A, Steinmann B, Duc G, Gitzelmann R
Department of Pediatrics, University of Zürich, Switzerland.
Eur J Pediatr. 1991 May;150(7):493-7. doi: 10.1007/BF01958431.
Intrauterine growth retardation, microcephaly, and developmental delay in two first cousins lead to the recognition of phenylketonuria (PKU) in their mothers, 24- and 23 year-old sisters with blood phenylalanine concentrations of approx. 1.2 mmol/l who had never been treated and had no overt mental retardation. Both mothers were shown to be homozygous for a point mutation leading to an Arg-to-Gln substitution at codon 261 of the phenylalanine hydroxylase gene, a mutation which has been recently identified and tentatively associated with a mild variant of PKU. Our observation suggests that homozygosity for the Arg-261-Gln mutation can indeed result in "mild" PKU with little or perhaps no mental retardation, but also indicates that in such women, who may go unrecognized if not screened for, blood phenylalanine is elevated enough to cause the maternal PKU syndrome in their offspring.
两名表亲出现宫内生长迟缓、小头畸形和发育迟缓,这使得她们的母亲——分别为24岁和23岁的姐妹,被诊断出患有苯丙酮尿症(PKU)。她们血液中的苯丙氨酸浓度约为1.2 mmol/l,从未接受过治疗,也没有明显的智力发育迟缓。研究表明,两位母亲均为苯丙氨酸羟化酶基因第261密码子处发生点突变的纯合子,该突变导致精氨酸被谷氨酰胺取代,此突变最近才被发现,并初步认定与一种轻度苯丙酮尿症变体有关。我们的观察结果表明,精氨酸-261-谷氨酰胺突变的纯合子确实可能导致“轻度”苯丙酮尿症,几乎没有或可能没有智力发育迟缓,但这也表明,对于这类未经过筛查可能未被识别的女性,其血液中的苯丙氨酸升高到足以在其后代中引发母体苯丙酮尿症综合征的程度。